Sun Medical Technology Research Corporation
Sun Medical Technology Research Corporation (or “Sun Medical”, www.evaheart.co.jp) is located in Suwa City, in the Nagano Prefecture of Japan. The Company was established on April 8, 1991 to develop and commercialize a concept for a Left Ventricular Assist System (LVAS) conceived by a cardiothoracic surgeon at Tokyo Women’s Medical University, Dr. Kenji Yamazaki. Using private and some government funds, Sun Medical developed the EVAHEART LVAS and in this process established collaborations with several universities including Wasada University, Tohoku University, Tokyo Women’s Medical University and the University of Pittsburgh. Arriving at a final clinical design in 2002, the Company completed final verification testing and, in 2005, initiated a clinical trial in Japan. The first-in-human use of the EVAHEART LVAS occurred at Tokyo Women’s Medical University on May 7, 2005. The Company completed the clinical trial consisting of 18 patients in 2008 and is working with the Japanese Pharmaceuticals and Medical Devices Agency (PMDA) to gain commercial approval of the device in Japan. Sun Medical will provide the EVAHEART LVAS to EVAHEART MEDICAL USA, Inc. for use in North America and EVAHEART MEDICAL INTERNATIONAL, Inc. for use worldwide.
Sun Medical is part of the MISUZU & SUN MEDICAL HLDGS Co., Ltd., which also includes Misuzu Industries Corporation, an international manufacturer of precision dies and components for various industries including watches, information devices, data processing and medical devices. For more information on Misuzu Industries, go to http://www.miszu.co.jp/en/.